3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
4
Thoracic
2
Head & Neck
2
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Prostatic Neoplasms
24
Wilms Tumor
9
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Glioma
7
Rhabdoid Tumor
6
Osteosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Sarcoma
5
Rhabdomyosarcoma
5
Central Nervous System Neoplasms
5
Sarcoma, Ewing
4
Lung Neoplasms
4
Carcinoma, Renal Cell
4
Melanoma
3
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Interventions
pembrolizumab
33
Nivolumab
15
atezolizumab
9
Cyclophosphamide
7
Paclitaxel
6
Ipilimumab
6
spartalizumab
5
fludarabine
5
Docetaxel
5
durvalumab
4
avelumab
4
Immune Checkpoint Inhibitors
4
Carboplatin
4
olaparib
3
cemiplimab
3
cabozantinib
3
Specimen Handling
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Interleukin-2
3
Gemcitabine
3
Fluorouracil
3
Cisplatin
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
sacituzumab govitecan
2
obinutuzumab
2
lenvatinib
2
epacadostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
X-Rays
×
Genitourinary
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled